Zura Bio Ltd - Class A Ordinary Shares, par value $0.0001 per share (ZURA)

CUSIP: G9TY5A101

Q1 2025 13F Holders as of 31 Mar 2025

Holder snapshot 7 signals
Share change
+2,833,079
Put/Call ratio
6000%
SEC-reported price per share
$1.29
Number of holders
74
Value change
+$1,915,127
Number of buys
29
Open additional details 1 more signal available
Number of sells
39
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
99,155,394

Security key

G9TY5A101

Report period

Q1 2025

Institutions

74

Top holders

10

Ownership snapshot

Top reported holders of ZURA - Zura Bio Ltd - Class A Ordinary Shares, par value $0.0001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
RA CAPITAL MANAGEMENT, L.P.
Disclosed value leader
SUVRETTA CAPITAL MANAGEME...
Comparable rows
15/15
Latest evidence
31 Dec 2024
13F 13D/G 3/4/5 Lead comparable stake: 4.9% 13D/G row: RA CAPITAL MANAGEMENT, L.P. Showing 1-6 of 15 holder rows.

Quick read

RA CAPITAL MANAGEMENT, L.P. leads the comparable SEC ownership view at 4.9%.

15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens RA CAPITAL MANAGEMENT, L.P.'s linked filing trail.
Comparable ownership Top 5
RA CAPITAL MANAGEMENT, L.P. 4.9%
PFIZER INC 4.6%
ADAR1 Capital Management, LLC 3.2%
SUVRETTA CAPITAL MANAGEMENT, LLC 4.9%
Deep Track Capital, LP 3.3%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
RA CAPITAL MANAGEMENT, L.P.
13F 13D/G
Company
4.9%
from 13D/G
$8,043,758
3,217,503 shares
31 Dec 2024
PFIZER INC
13F 13D/G 3/4/5
Company · Pfizer Inc. 13-5315170 · 10%+ Owner
4.6%
from 13D/G
$7,425,055
2,970,022 shares
31 Dec 2024
ADAR1 Capital Management, LLC
13F 13D/G
Company
3.2%
from 13D/G
$5,193,128
2,077,251 shares
31 Dec 2024
SUVRETTA CAPITAL MANAGEMENT, LLC
13F
Company
13F
4.9%
$12,152,348
4,860,939 shares
31 Dec 2024
Deep Track Capital, LP
13F
Company
13F
3.3%
$8,209,458
3,283,783 shares
31 Dec 2024
GREAT POINT PARTNERS LLC
13F
Company
13F
3.2%
$7,925,485
3,170,194 shares
31 Dec 2024
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q1 2025

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
74
Shares
45,725,666
Rows available
74
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q1 2025 vs Q4 2024 Across Filers

Q4 2024 holders
87
Q1 2025 holders
74
Holder diff
-13
Investor Q4 2024 Shares Q1 2025 Shares Share Diff Share Chg % Q4 2024 value Q1 2025 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .